Cargando…
Biological activity and structure–activity relationship of dehydrodieugenol B analogues against visceral leishmaniasis
Visceral leishmaniasis is a neglected protozoan disease with high mortality. Existing treatments exhibit a number of limitations, resulting in a significant challenge for public health, especially in developing countries in which the disease is endemic. With a limited pipeline of potential drugs in...
Autores principales: | Amaral, Maiara, Asiki, Hannah, Sear, Claire E., Singh, Snigdha, Pieper, Pauline, Haugland, Marius M., Anderson, Edward A., Tempone, Andre G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
RSC
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10357944/ https://www.ncbi.nlm.nih.gov/pubmed/37484568 http://dx.doi.org/10.1039/d3md00081h |
Ejemplares similares
-
Synthesis and Structure–Activity Relationship
of Dehydrodieugenol B Neolignans against Trypanosoma cruzi
por: Sear, Claire E., et al.
Publicado: (2020) -
Sertraline Delivered in Phosphatidylserine Liposomes Is Effective in an Experimental Model of Visceral Leishmaniasis
por: Romanelli, Maiara Maria, et al.
Publicado: (2019) -
Synthetic Analogues of Gibbilimbol B Induce Bioenergetic Damage and Calcium Imbalance in Trypanosoma cruzi
por: Amaral, Maiara, et al.
Publicado: (2023) -
Piperazine amides with desirable solubility, physicochemical and drug-like properties: Synthesis and evaluation of the anti-Trypanosoma cruzi activity
por: Varela, Marina T., et al.
Publicado: (2023) -
Visceral leishmaniasis
por: Sundar, Shyam
Publicado: (2015)